Axis Biochemicals ASA is a Norwegian private company located in Oslo, with subsidiaries in the United States, that makes diagnostic products. The firm was founded by Erling M. H. Sundrehagen. Svein Wilhelm Faye Lien is the CEO, in this role since 1993.

Roche Diagnostics GmbH, part of Roche Holding AG, is a company headquartered in Mannheim, Germany, involved in laboratory analytical instruments. Andreas Schmitz and Claus Haberda are the current co-CEOs of the firm. On January 01, 1999 Roche Holding AG acquired Roche Diagnostics GmbH.

MediSense, Inc. was engaged in the development, manufacture, and marketing of self-testing blood glucose monitoring systems that enabled people with diabetes to manage their disease effectively.

Genetics International, Inc. produces vegetable and field seeds. The firm involves in the breeding of field crops, such as alfalfa, sorghum, and maize, as well as vegetable species. It offers its products through a network of distributors in Algeria, Dubai, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Saudi Arabia, Sudan, Syria, and Yemen. The company is headquartered in Yuba City, CA.

Axis-Shield Diagnostics Ltd., a subsidiary of Abbott Laboratories, is a British company located in Dundee. The firm develops novel proprietary diagnostic tests.\nThe company says this about itself: Our expertise encompasses the development of novel proprietary diagnostic tests in areas of clinical need and their incorporation onto the menus of the high throughput analysers of our partners, using a variety of assay technologies.

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Newsouth Innovations Pty Ltd., part of The University of New South Wales, is a company headquartered in Sydney, Australia, that provides support services for university of new south wales inventors turn their discoveries into innovations. The firm was founded in 1959. Kevin Cullen is the current CEO, occupying that position since 2011.

GenMont Biotech Inc. is a Taiwan-based company engaged in the manufacture and distribution of functional lactobacillus. The Company's major products are applied primarily to enhance human immunity against dust allergy and digestive system health care, including lactobacillus paracasei, lactobacillus rhamnosus, lactobacillus casei, lactobacillus plantarum, lactobacillus fermentum, lactobacillus salivarius, lactobacillus acidophilus,

Wuhan Nobel Pharmaceutical Co., Ltd., established on 2010-11-22, The business scope includes Class Ι medical devices,disinfection products,hygiene products,cosmetic,Production of daily chemicals and animal and plant extracts;Ι class medical device,disinfection products,hygiene products,cosmetic,Daily Chemicals,Chemical Products(Does not contain dangerous goods),animal and plant extracts,hardware,Glass product,household appliances,Sales and online sales of experimental equipment;medicine,Biological product,medical instruments,Daily Chemicals,cosmetic,Healthy food,Chemical Products(Does not contain dangerous goods),Research and development of animal and plant extracts,Technical Consulting and Services.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

SD Biosensor, Inc. develops and manufactures cholesterol, blood glucose testing and monitoring equipment. Its products include Standard Q, Standard F, Standard E, Standard M and BGMS. The company is founded on December 21, 2010 and is headquartered in Suwon-si, South Korea.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

TrueBinding is an early-stage biotherapeutics development company focused on creating new and exciting molecules for applications in Immuno oncology and other disease areas with a great unmet medical needs. Based on the application of the TruebindingTM platform, TrueBinding has to date discovered 6 novel ligands, previously uncharacterized, to receptors of known checkpoint inhibitor pathways.